13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
94 檔
27.7%
The Q1 2025 SEC filing reveals that Simplify Asset Management Inc. held a total portfolio value of $7.2B, covering 94 public equity positions.
In Q1 2025, Simplify Asset Management Inc. displayed an active expansion posture, initiating 50 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 25.33% | -0.08% | +21.89% | |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 18.27% | — | — | |
| 3 | GLD | Spdr Gold Shares | ETF-Commodities | 15.30% | +0.57% | NEW | |
| 4 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 11.29% | +0.69% | +31.35% | |
| 5 | MSTR | Strategy Inc | Stock-Tech | 4.45% | — | +23.19% | |
| 6 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 4.11% | -0.07% | — | |
| 7 | QIS | Simplify Multi-qis Alt ETF | ETF-Other | 3.51% | -0.17% | +2390.16% | |
| 8 | SPUC | Simplify US Eqty Plus Up | ETF-Other | 3.34% | +0.01% | — | |
| 9 | NMB | Simplify National Muni Bnd | ETF-Other | 2.64% | -0.04% | -0.16% | |
| 10 | TYA | Simplify Intermediate Term | ETF-Other | 1.96% | — | +2.73% | |
| 11 | CDX | Simplify High Yield ETF | ETF-High Yield | 1.12% | — | — | |
| 12 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 1.02% | -0.04% | — | |
| 13 | FOXY | Simplify Currency Strtgy ETF | ETF-Other | 0.47% | — | — | |
| 14 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.44% | +0.01% | +65.99% | |
| 15 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 0.39% | — | -11.01% | |
| 16 | DHR | Danaher CORP | Stock-Healthcare | 0.32% | +0.02% | +2965.49% | |
| 17 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.26% | +0.23% | +11.36% | |
| 18 | CAH | Cardinal Health Inc | Stock-Healthcare | 0.26% | +0.09% | NEW | |
| 19 | CI | THE Cigna Group | Stock-Healthcare | 0.26% | — | +70.18% | |
| 20 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.26% | +0.14% | -1.85% | |
| 21 | ADMA | Adma Biologics Inc | Stock-Healthcare | 0.26% | — | -10.79% | |
| 22 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.23% | -0.04% | -9.37% | |
| 23 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.22% | — | -44.99% | |
| 24 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.20% | — | -30.04% | |
| 25 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.17% | +0.03% | +0.52% | |
| 26 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.16% | — | +17.18% | |
| 27 | ABBV | Abbvie Inc | Stock-Healthcare | 0.16% | +0.07% | — | |
| 28 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.14% | — | — | |
| 29 | PCT | Purecycle Technologies Inc | Stock-Other | 0.13% | +0.20% | -56.07% | |
| 30 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 0.13% | +0.15% | NEW | |
| 31 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.13% | — | +2.98% | |
| 32 | PCRX | Pacira Biosciences Inc | Stock-Other | 0.12% | +0.01% | +255.15% | |
| 33 | AGNC | Agnc Investment CORP | Stock-Real Estate | 0.12% | — | +124.00% | |
| 34 | PM | Philip Morris International | Stock-Consumer Staples | 0.11% | — | — | |
| 35 | HODL | Vaneck Bitcoin ETF | ETF-Crypto | 0.11% | — | — | |
| 36 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.10% | — | — | |
| 37 | ALHC | Alignment Healthcare Inc | Stock-Other | 0.09% | -0.05% | EXIT | |
| 38 | RMD | Resmed Inc | Stock-Healthcare | 0.09% | — | -63.17% | |
| 39 | IJR | Ishares Core S&p Small-cap E | ETF-Small Cap | 0.09% | — | +21.09% | |
| 40 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.09% | +0.01% | -53.92% | |
| 41 | TSLL | Dirx Dly Tsla Bul 2x Etf-aui | ETF-Other | 0.09% | — | +34.75% | |
| 42 | SNY | Sanofi-adr | Stock-Healthcare | 0.08% | — | +0.52% | |
| 43 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 0.08% | — | — | |
| 44 | APLT | Applied Therapeutics Inc | Stock-Other | 0.08% | — | +59.27% | |
| 45 | RITM | Rithm Capital CORP | Stock-Real Estate | 0.08% | — | +8.53% | |
| 46 | NLY | Annaly Capital Management In | Stock-Real Estate | 0.08% | — | +31.04% | |
| 47 | HARD | Simplify Commodities Str K-1 | ETF-Other | 0.08% | — | — | |
| 48 | RFIX | Simplify Bond Bull ETF | ETF-Other | 0.07% | — | — | |
| 49 | CTA | Simplify Managed Futures St | ETF-Other | 0.07% | -0.07% | EXIT | |
| 50 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.07% | — | — |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 94 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IVV, SPY, GLD) accounted for 27.7% of total reported equity market value during Q1 2025.
Top New Position Initiated
IVV
市值: $676.2M
During Q1 2025, Simplify Asset Management Inc.'s top holdings by market value included IVV (25.3%)、SPY (18.3%)、GLD (15.3%). The largest single position, IVV, represented 25.3% of total portfolio value.
In Q1 2025, Simplify Asset Management Inc. made 50 total portfolio adjustments, initiating 50 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.